STRYKER NEUROVASCULAR CORK NEUROFORM ATLAS 4.0MM X 24MM NO TIP- IDE; STENT, INTRACRANIAL NEUROVASCULAR
|
Back to Search Results |
|
Catalog Number M003SZAS40240C |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Stroke/CVA (1770); Stenosis (2263); No Known Impact Or Consequence To Patient (2692)
|
Event Date 11/06/2018 |
Event Type
Injury
|
Manufacturer Narrative
|
The device history record review confirms that the device met all material, assembly and performance specifications.The subject device is not available; therefore, functional testing as well as physical analysis cannot be performed.The initial information indicates that the reported events are not related to the atlas stent and that the atlas was used successfully.It was determined by the cec that the adverse event was related to the stent.There was no allegation of any defect against the atlas.The treatment was carried out in response to coil compaction.The as reported events are known and anticipated complications to these types of procedures and patient condition, and are listed as such in the device dfu; therefore, an assignable cause classification of anticipated procedural complication will be assigned to this complaint.Based on the information currently available an assignable cause for this event cannot be determined.Subject devices remain implanted.
|
|
Event Description
|
The patient underwent successful stent-assisted coil embolization of an aneurysm located at the basilar apex.Raymond scale post procedure was 1.It was reported that 12 month-post procedure, there was compaction of the aneurysm and endovascular re-intervention was required.According to the clinical events committee (cec),the aneurysm compaction was related to the procedure and to the subject device stent.
|
|
Event Description
|
The patient underwent successful stent-assisted coil embolization of an aneurysm located at the basilar apex.Raymond scale post procedure was 1.It was reported that 12 month-post procedure, there was compaction of the aneurysm and endovascular re-intervention was required.According to the clinical events committee (cec),the aneurysm compaction was related to the procedure and to the subject device stent.Additional information received on 18-june-2021 reported that 281 days post procedure with the subject stent, the patient had a proximal stent stenosis that resolved with no residual effects without intervention and an acute ischemic stroke that was treated with unknown medication.No other information is available.
|
|
Manufacturer Narrative
|
B2 ¿ outcomes attributed to ae: updated.B5 ¿ executive summary: updated.B6 ¿ relevant tests and lab data: updated.F10/h6 ¿ clinical signs code grid, health impact code grid: updated.H6 ¿ results code, conclusion code: updated.H10 - additional mfg narrative: updated.The subject device is not available; therefore, visual and functional testing as well as physical analysis cannot be performed.Based on the results of the dhr review, there is no indication that the device, labelling or packaging failed to meet its specifications when release.The reported event is covered in the device directions for use (dfu).As well, the risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.The direction for use (dfu) for this product covers patient in-stent stenosis and patient stroke as potential complication of a procedure.The reported complaint could not be confirmed, and it could not be definitively determined if the device failed to meet specifications because the product was not returned.The initial information indicates that the reported events are not related to the atlas stent and that the atlas was used successfully.It was determined by the cec that the adverse event was related to the stent.The coil compaction was assessed by the site to be coil related.The treatment was carried out in response to coil compaction.The as reported events are known and anticipated complications to these types of procedures and patient condition, and are listed as such in the device dfu, therefore an assignable cause classification of anticipated procedural complication will be assigned to this complaint.H3 other text : subject devices remain implanted.
|
|
Search Alerts/Recalls
|
|
|